Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance.
Acute heart failure
Approche multidisciplinaire
Comorbidities
Comorbidités
Discharge
Guide pratique
Heart failure
Heart failure management
Insuffisance cardiaque
Insuffisance cardiaque aiguë
Multidisciplinary approach
Optimisation du traitement
Parcours patient
Pathway
Practical guide
Prise en charge de l’insuffisance cardiaque
Treatment optimization
Écoulement
Journal
Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
25
02
2021
accepted:
07
05
2021
pubmed:
19
7
2021
medline:
4
2
2022
entrez:
18
7
2021
Statut:
ppublish
Résumé
Heart failure (HF) has high event rates, mortality, and is challenging to manage in clinical practice. Clinical management is complicated by complex therapeutic strategies in a population with a high prevalence of comorbidity and general frailty. In the last four years, an abundance of research has become available to support multidisciplinary management of heart failure from within the hospital through to discharge and primary care as well as supporting diagnosis and comorbidity management. Within the hospital setting, recent evidence supports sacubitril-valsartan combination in frail, deteriorating or de novo patients with LVEF≤40%. Furthermore, new strategies such as SGLT2 inhibitors and vericiguat provide further benefit for patients with decompensating HF. Studies with tafamidis report major clinical benefits specifically for patients with ATTR cardiac amyloidosis, a remaining underdiagnosed and undertreated disease. New evidence for medical interventions supports his bundle pacing to reduce QRS width and improve haemodynamics as well as ICD defibrillation for non-ischemic cardiomyopathy. The Mitraclip reduces hospitalisations and mortality in patients with symptomatic, secondary mitral regurgitation and ablation reduces mortality and hospitalisations in patients with paroxysmal and persistent atrial fibrillation. In end-stage HF, the 2018 French Heart Allocation policy should improve access to heart transplants for stable, ambulatory patients and, mechanical circulatory support should be considered to avoid deteriorating on the waiting list. In the community, new evidence supports that improving discharge education, treatment and patient support improves outcomes. The authors believe that this review fills the gap between the guidelines and clinical practice and provides practical recommendations to improve HF management.
Identifiants
pubmed: 34274113
pii: S0003-3928(21)00068-8
doi: 10.1016/j.ancard.2021.05.004
pii:
doi:
Substances chimiques
Aminobutyrates
0
Biphenyl Compounds
0
sacubitril
17ERJ0MKGI
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
41-52Informations de copyright
Copyright © 2021 Elsevier Masson SAS. All rights reserved.